Papers/PMID:37653378
Three-dimensional facial swelling evaluation of pre-operative single-dose of prednisone in third molar surgery: a split-mouth randomized controlled trial.
BMC oral health2023The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
prednisone — decreases visual analogue scale pain intensity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“PG showed significantly lower pain values compared to CG, both at T1 (PG: 3.1 ± 1.5; CG: 4.6 ± 1.8; p = 0.0006) and T2 (PG: 1.0 ± 0.8; CG: 1.9 ± 1.4; p = 0.0063).”
Quoted verbatim from Three-dimensional facial swelling evaluation of pre-operative single-dose of prednisone in third molar surgery: a split-mouth randomized controlled trial.. - Study
- RCT
- Dose
- single dose of 25 mg, 1 hour before third molar extraction
- Population
- Healthy adults aged 18 to 32 years undergoing surgical extraction of both mandibular third molars, split-mouth design, 32 patients and 64 extractions; postoperative pain on a 0 to 10 visual analogue scale at 2 days (T1) and 7 days (T2) after surgery; all patients also received paracetamol, chlorhexidine rinses and antibiotic prophylaxis
Three-dimensional facial swelling evaluation of pre-operative single-dose of prednisone in third molar surgery: a split-mouth randomized controlled trial.2023PMID:37653378Permalink